| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Levofloxacin |
| Brand | Quinsair® |
| Indication | For the management of chronic pulmonary infections due to Pseudomonas aeruginosa in adult patients with Cystic Fibrosis. |
| Assessment Process | |
| Rapid review commissioned | 10/02/2016 |
| Rapid review completed | 01/03/2016 |
| Rapid review outcome | Full pharmacoeconomic assessment recommended at the submitted price. |
The HSE has approved reimbursement following confidential price negotiations.